Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm

Abstract

Postnatal dexamethasone use in extremely preterm infants is associated with increased risks of respiratory hospital admissions and neurodevelopmental impairment. These associations were not explained by excess neonatal morbidities.